Home LiteratureArticle Details
PMID: 8046749 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus.

Journal of molecular biology ·Vol. 240 ·No. 5 ·1994-07-29 ·Pages 434-44

Torrent C, Bordet T, Darlix JL

Abstract

A sequence of the rat retrotransposon virus-like 30 S RNA (VL30) located next to the 5' end of the Harvey murine sarcoma virus (HaMSV) genome was recently found to form stable dimeric RNA in vitro and to direct the efficient packaging of VL30-derived recombinant RNAs into MuLV virions. To study the structure-function relationships of the rat VL30 dimerization-encapsidation signal (E/DLS), we have performed biochemical and genetic studies of rat VL30 RNA dimerization in vitro. The results show that temperature and specific cation/RNA interactions are important for VL30 dimerization in vitro. VL30 RNA dimerization is optimal at 55 degrees C and Li+ dramatically enhances the stability of VL30 dimeric RNA. In addition, a genetic analysis of VL30 RNA dimerization reveals that a 5' G-rich sequence is critical for dimer formation and that a UGUCUUGUC repeat contributes to VL30 dimer stability. Interestingly enough, substitution of an A for a G in the 5' G-rich sequence is sufficient to abolish VL30 RNA dimerization in vitro. Taken together, these biochemical and genetic data indicate that dimerization of VL30 RNA involves non-canonical base-pairings and possible purine-purine interactions. Nucleocapsid protein NCp10 of murine leukemia virus (MuLV), a gag-encoded protein that is tightly associated with genomic RNA in the virion core, has been shown to have nucleic acid binding and annealing activities. Here we report that the viral NCp10 protein is able to bind tightly to annealing activities. Here we report that the viral NCp10 protein is able to bind tightly to the retrotransposon VL30 RNA and to activate its dimerization. Moreover, mutations in the 5' G-rich sequence of the VL30 dimerization sequence impaired NCp10 binding to RNA. Recombinant MLV-VL30 vectors with mutations in the VL30 dimerization sequence were constructed. Results obtained in vivo clearly show that the mutations that had a deleterious effect on the packaging of MLV-VL30 retroviral vector in vivo were those that impaired VL30 RNA dimerization and interactions with NCp10 in vitro, even the single mutation in the 5' G-rich region. Therefore, these findings suggest that packaging of VL30 RNA into MuLV virions requires specific interactions between RNA dimerization sequences and viral NC protein molecules.

MeSH Terms
3T3 Cells Animals Base Sequence DNA Transposable Elements/genetics Gene Products, gag/metabolism,pharmacology Leukemia Virus, Murine/physiology Lithium Chloride/pharmacology Mice Molecular Sequence Data Mutation/physiology Nucleic Acid Conformation/drug effects RNA, Viral/drug effects,metabolism Rats Repetitive Sequences, Nucleic Acid/physiology Sarcoma Viruses, Murine/genetics Temperature Viral Core Proteins/metabolism,pharmacology Virion/physiology Virus Replication/genetics
Chemicals
DNA Transposable Elements Gene Products, gag RNA, Viral Viral Core Proteins retroviral nucleocapsid protein NCp10, Moloney murine leukemia virus Lithium Chloride
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Torrent C
LaboRetro INSERM, Unité de virologie humaine U412, Ecole Normale Supérieure de Lyon, France.
Bordet T
Darlix J L
Article Info
Journal
Journal of molecular biology
Abbr.
J Mol Biol
ISSN
0022-2836
Published
1994-07-29
Pages
434-44
Language
English
Region
England
NLM ID
2985088R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com